Acute effects of transjugular intrahepatic portosystemic stent-shunt (TIPSS) procedure on renal blood flow and cardiopulmonary hemodynamics in cirrhosis

American Journal of Gastroenterology

Volumn 93, Issue 12, 1998, Pages 2463-2468

  Stanley, Adrian J ^a   Redhead, Doris N ^a   Bouchier, Ian A D ^a   Hayes, Peter C ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASCITES; CARDIOPULMONARY HEMODYNAMICS; CLINICAL ARTICLE; CORRELATION FUNCTION; FEMALE; HEART OUTPUT; HEART RATE; HUMAN; KIDNEY BLOOD FLOW; LIVER CIRRHOSIS; LUNG CAPILLARY PRESSURE; MALE; MEAN ARTERIAL PRESSURE; PORTAL VEIN BLOOD PRESSURE; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; THERMODILUTION;

BLOOD PRESSURE; CORONARY CIRCULATION; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PORTAL VEIN; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PULMONARY CIRCULATION; RENAL CIRCULATION;

EID: 0032417743     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00705.x     Document Type: Article

References (34)

1. 1. Groszmann RJ. Hyperdynamic circulation of liver disease 40 years later: Pathophysiology and clinical consequences. Hepatology 1994; 20:1359-63.
2. 2. Marato A, Gines P, Arroyo V, et al. Brachial and femoral artery flow in cirrhosis: Relationship to kidney dysfunction. Hepatology 1993;17: 788-93.
3. 3. Niedberger M, Scrier RW. Pathogenesis of sodium and water retention in liver disease. In: Boyer JL, Ockner RK, eds. Progress in liver disease. Vol X. Philadelphia: Saunders, 1992:329-47.
4. 4. Forrest EH, Jalan RJ, Hayes PC. Review article: Renal circulatory changes in cirrhosis - pathogenesis and therapeutic prospects. Aliment Pharmacol Ther 1996;10:219-31.
5. 5. Richter GM, Noeldge G, Palmaz JC, Rossle M. The transjugular intrahepatic portosystemic stent-shunt (TIPSS): Results of a pilot study. Cardiovasc Intervent Radiol 1990;13:200-7.
6. 6. Shiffman ML, Jeffers L, Hoofnagle JH, Tralka TS. The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: A conference sponsored by the National Digestive Diseases Advisory Board. Hepatology 1995;22:1591-7.
7. 7. Rossle M, Haag K, Ochs A, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994;330:165-71.
8. 8. LaBerge JM, Somberg KA, Lake JR, et al. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: Results in 90 patients. Gastroenterology 1995;108:1143-51.
9. 9. Stanley AJ, Jalan R, Forrest EH, et al. Long term follow-up of Transjugular Intrahepatic Portosystemic Stent-shunt (TIPSS) for the treatment of portal hypertension: Results in 130 patients. Gut 1996;39: 479-85.
10. 10. Schrier RW, Arroyo V, Bernardi M, et al. Peripheral arterial vasodilatation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;8:1151-7.
11. 11. Azoulay D, Castaing D, Dennison A, et al. Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: Preliminary report of a prospective study. Hepatology 1994;19:129-32.
12. 12. Colombato LA, Spahr L, Martinet JP, et al. Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients. Gut 1996;39:600-4.
13. 13. Van der Linden P, Le Moine O, Ghysels M, et al. Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: Effects on right ventricular function. Hepatology 1996;23:1003-11.
14. 14. Ochs A, Rossle M, Haag K, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995;332:1192-7.
15. 15. Wong F, Sniderman K, Liu P, et al. Transjugular intrahepatic portosystemic stent shunt: Effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Int Med 1995;122:816-22.
16. 16. Somberg KA, Lake JR, Tomlanovich SJ, et al. Transjugular Intrahepatic Portosystemic Shunts for refractory ascites: Assessment of clinical and hormonal response and renal function. Hepatology 1995;21: 709-16.
17. 17. Spahr L, Fenyves D, Nguyen VV, et al. Improvement of hepatorenal syndrome by transjugular intrahepatic portosystemic shunt. Am J Gastroenterol 1995;90:1169-71.
18. 18. Lang F, Tschernko E, Schulze E, et al. Hepatorenal reflex regulating kidney function. Hepatology 1991;14:590-4.
19. 19. Jalan R, Forrest EH, Redhead DN, et al. Reduction in renal blood flow following acute increase in the portal pressure: Evidence for the existence of a hepatorenal reflex in man? Gut 1997;40:664-70.
20. 20. Hayes PC, Terrace D, Peaston I, et al. Computerised system for the continuous measurement of azygos venous blood flow. Gut 1992;33: 372-4.
21. 21. Forrest EH, Bouchier IADB, Hayes PC. Acute effect of low dose theophylline on the circulatory disturbances of cirrhosis. Gut 1997;40: 139-44.
22. 22. Chalmers N, Redhead DN, Simpson KJ, Hayes PC. Transjugular intrahepatic portosystemic stent-shunt (TIPSS): Early clinical experience. Clin Radiol 1992;46:166-9.
23. 23. DiBona GF, Sawin LL. Renal nerve activity in conscious rats during volume expansion and depletion. Am J Physiol 1985;248:F15-23.
24. 24. Solis-Herruzo JA, Duran A, Favela V, et al. Effects of lumbar sympathetic block on kidney function in cirrhotic patients with hepatorenal syndrome. J Hepatol 1987;5:167-73.
25. 25. Bernardi M, Santini C, Trevisani F, et al. Renal function impairment induced by change in posture in patients with cirrhosis and ascites. Gut 1985;26:629-35.
26. 26. Barnardo DE, Summerskill WHJ, Strong CG, Baldus WP. Renal function, renin activity and endogenous vasoactive substances in cirrhosis. Am J Dig Dis 1970;15:419-25.
27. 27. Wong F, Massie D, Hsu P, Dudley F. Indomethacin-induced renal dysfunction in patients with well-compensated cirrhosis. Gastroenterology 1993;104:869-76.
28. 28. Moore K, Wendon J, Frazer M, et al. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med 1992;327:1774-8.
29. 29. Llach J, Gines P, Arroyo V, et al. Effect of dipyridamole on the kidney function in cirrhosis. Hepatology 1993;17:59-64.
30. 30. Wong F, Sniderman K, Liu P, Blendis L. The mechanisms of the initial natriuresis after transjugular intrahepatic portosystemic shunt. Gastroenterology 1997;112:899-907.
31. 31. Quiroga J, Sangro B, Nunez M, et al. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: Effect on clinical, renal, humoral and hemodynamic parameters. Hepatology 1995;21: 986-94.
32. 32. Jalan R, Redhead DN, Thomas H, et al. Mechanisms of changes in renal handling of sodium following transjugular intrahepatic portal systemic stent-shunt (TIPSS). Eur J Gastroenterol Hepatol 1996;8: 1111-6.
33. 33. Lebrec D, Giuily N, Hadengue A, et al. Transjugular Intrahepatic Portosystemic Shunts: Comparison with paracentesis in patients with cirrhosis and refractory ascites: A randomized trial. J Hepatol 1996; 25:135-44.
34. 34. Brenner M, Schaer GL, Mallory DL, et al. Detection of renal blood flow abnormalities in septic and critically ill patients using a newly designed indwelling thermodilution renal vein catheter. Chest 1990; 98:170-9.